Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Size And Share Report 2023-2030


(MENAFN- The Express Wire) -

Global "lysosomal acid lipase (lal) deficiency treatment market" Research Report 2023 is spread across 125 pages and provides Size, Share, Growth, and Forecast with exclusive vital statistics, data, information, trends, and competitive landscape details in this niche sector.Lysosomal Acid Lipase (LAL) Deficiency Treatment Market research report offers New Insight updates on Business Strategies including Mergers, Acquisitions, Partnerships, R and D, Expansion Plans and Collaborations adopted by these Major Global Players, Revenue by Type ( Wolman Disease (WD), Cholesteryl Ester Storage Disease (CESD) ), Forecasted Market Size by Application ( Enzyme Replacement Therapy, Lipid-Modifying Agents (Statins), Surgery (Liver Transplant), Stem Cell Transplantation, Supportive Care ) ask for a sample report

The global Lysosomal Acid Lipase (LAL) Deficiency Treatment size is segmented on the basis of application, end user, and region, with a focus on manufacturers in different regions. The study has detailed the analysis of different factors that increase the industry's growth. This study also provides the scope of different segments and applications that can potentially influence the industry in the future. Pricing analysis is covered in this report according to each type, manufacturer, regional analysis, and price. The Lysosomal Acid Lipase (LAL) Deficiency Treatment Share report provides an overview of market value structure, cost drivers, and various driving factors and analyzes the industry atmosphere, then studies the global outline of industry size, demand, application, revenue, product, region, and segments. In addition, this report introduces the market competition situation among the distributors and manufacturers profile, market value analysis, and cost chain structure are covered in this report.

Get a sample PDF of the report -

TOP Manufactures in Lysosomal Acid Lipase (LAL) Deficiency Treatment Market are: -

  • Pfizer, Inc
  • Merck and Co., Inc
  • AstraZeneca plc
  • Alexion Pharmaceutical Inc
  • Teva Pharmaceutical Industries Ltd.

get a sample copy of the lysosomal acid lipase (lal) deficiency treatment market report 2023

Brief Description of Lysosomal Acid Lipase (LAL) Deficiency Treatment Market:

The Lysosomal Acid Lipase (LAL) Deficiency Treatment market revenue was Million USD in 2016, grew to Million USD in 2021, and will reach Million USD in 2026, with a CAGR of during 2021-2026.Considering the influence of COVID-19 on the global Lysosomal Acid Lipase (LAL) Deficiency Treatment market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Forecast by regions, type and application, with sales and revenue, from 2021 to 2029. Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Share, distributors, major suppliers, changing price patterns and the supply chain of raw materials is highlighted in the report.Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Size report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.This Report Focuses on the Lysosomal Acid Lipase (LAL) Deficiency Treatment Market manufacturers, to study the sales, value, market share and development plans in the future. It is Define, describe and forecast the Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Growth by type, application, and region to Study the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. Know significant trends and factors driving or inhibiting the Lysosomal Acid Lipase (LAL) Deficiency Treatment Market growth opportunities in the market for stakeholders by identifying the high growth segments. Strategically it examines each submarket with respect to individual growth trend and their contribution to the Lysosomal Acid Lipase (LAL) Deficiency Treatment Market.

Inquire more and share questions if any before the purchase on this report at:

What are the major type and applications, of Lysosomal Acid Lipase (LAL) Deficiency Treatment?

Market segment by Type, the product can be split into

  • Wolman Disease (WD)
  • Cholesteryl Ester Storage Disease (CESD)

Market segment by Application, split into

  • Enzyme Replacement Therapy
  • Lipid-Modifying Agents (Statins)
  • Surgery (Liver Transplant)
  • Stem Cell Transplantation
  • Supportive Care

The Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Trends , development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered.The global Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Growth is anticipated to rise at a considerable rate during the forecast period, between 2021 and 2029. In 2021, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

to know how covid-19 pandemic and russia ukraine war will impact this market - request a sample

Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Trend for Development and marketing channels are analysed. Finally, the feasibility of new investment projects is assessed and overall research conclusions offered. Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Report also mentions market share accrued by each product in the Lysosomal Acid Lipase (LAL) Deficiency Treatment market, along with the production growth.

Regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

Europe (Covered in Chapter 7 and 13)

Asia-Pacific (Covered in Chapter 8 and 13)

Middle East and Africa (Covered in Chapter 9 and 13)

South America (Covered in Chapter 10 and 13)

Key Objectives of This Report are: -

  • The market analysis report provides a comprehensive overview of the industry, including both qualitative and quantitative analysis based on the segmentation of economic and non-economic factors.
  • The report also includes market value data in USD billion for each segment and sub-segment, as well as information on the fastest-growing and dominant segments and regions.
  • Furthermore, the report analyzes the market consumption and factors affecting the market in various regions.
  • It also features a competitive landscape, ranking major players, and detailing new service/product launches, partnerships, business expansions, and acquisitions in the past five years.
  • The report extensively profiles significant market players, providing company overviews, insights, product benchmarking, and SWOT analysis.
  • It also offers an outlook on the industry's current and future market, with growth opportunities, drivers, challenges, and restraints for emerging and developed regions.
  • Moreover, the report includes an in-depth analysis of the market from various perspectives, including Porter's five forces analysis and Value Chain analysis.
  • It presents a market dynamics scenario and growth opportunities for the coming years, with 6-month post-sales analyst support.
  • Finally, the report can be customized per specific queries or requirements, with the sales team available to address any concerns.

Purchase this report (Price 3000 USD for a single-user license) -

Frequently Asked Questions?

  • What is the projected market size and growth rate of the Lysosomal Acid Lipase (LAL) Deficiency Treatment?

    Lysosomal Acid Lipase (LAL) Deficiency Treatment was valued at USD Billion in 2021 and is projected to reach USD Billion by 2030, growing at a CAGR from 2023 to 2030.

  • What are the key driving factors for the growth of the Lysosomal Acid Lipase (LAL) Deficiency Treatment?

    Lysosomal Acid Lipase (LAL) Deficiency Treatment markets include technological advancements, changing consumer behavior, increasing demand from emerging economies, government initiatives, favorable regulatory policies, and increasing investment in research and development.

  • What are the top players operating in the Lysosomal Acid Lipase (LAL) Deficiency Treatment?

    The major players in the market are Pfizer, Inc, Merck and Co., Inc, AstraZeneca plc, Alexion Pharmaceutical Inc, Teva Pharmaceutical Industries Ltd..

  • What segments are covered in the Lysosomal Acid Lipase (LAL) Deficiency Treatment report?

    The Global Lysosomal Acid Lipase (LAL) Deficiency Treatment is Segmented on the basis of Type, And Geography.

  • How can I get a sample report/company profile for the Lysosomal Acid Lipase (LAL) Deficiency Treatment?

    The sample report for the Lysosomal Acid Lipase (LAL) Deficiency Treatment can be obtained on demand from the website. Also, 24*7 chat support and direct call services are provided to procure the sample report.

    Customization of the Report

    • In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

    Detailed TOC of Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Insights and Forecast to 2030

    Major Points from Table of Contents


    1 Lysosomal Acid Lipase (LAL) Deficiency Treatment Introduction and Market Overview
    1.1 Objectives of the Study
    1.2 Overview of Lysosomal Acid Lipase (LAL) Deficiency Treatment
    1.3 Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Scope and Market Size Estimation
    1.3.1 Market Concentration Ratio and Market Maturity Analysis
    1.3.2 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Revenue and Growth Rate from 2016-2026
    1.4 Market Segmentation
    1.4.1 Types of Lysosomal Acid Lipase (LAL) Deficiency Treatment
    1.4.2 Applications of Lysosomal Acid Lipase (LAL) Deficiency Treatment
    1.4.3 Research Regions
    1.5 Market Dynamics
    1.5.1 Lysosomal Acid Lipase (LAL) Deficiency Treatment Industry Trends
    1.5.2 Lysosomal Acid Lipase (LAL) Deficiency Treatment Drivers
    1.5.3 Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Challenges
    1.5.4 Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Restraints
    1.6 Industry News and Policies by Regions
    1.6.1 Industry News
    1.6.2 Industry Policies
    1.7 Mergers and Acquisitions, Expansion Plans
    1.8 Lysosomal Acid Lipase (LAL) Deficiency Treatment Industry Development Trends under COVID-19 Outbreak
    1.8.1 Global COVID-19 Status Overview
    1.8.2 Influence of COVID-19 Outbreak on Lysosomal Acid Lipase (LAL) Deficiency Treatment Industry Development
    2 Industry Chain Analysis
    2.1 Upstream Raw Material Supply and Demand Analysis
    2.1.1 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Major Upstream Raw Material and Suppliers
    2.1.2 Raw Material Source Analysis
    2.2 Major Players of Lysosomal Acid Lipase (LAL) Deficiency Treatment
    2.2.1 Major Players Manufacturing Base of Lysosomal Acid Lipase (LAL) Deficiency Treatment in 2020
    2.2.2 Major Players Market Distribution in 2020
    2.3 Lysosomal Acid Lipase (LAL) Deficiency Treatment Manufacturing Cost Structure Analysis
    2.3.1 Production Process Analysis
    2.3.2 Manufacturing Cost Structure of Lysosomal Acid Lipase (LAL) Deficiency Treatment
    2.3.3 Labor Cost of Lysosomal Acid Lipase (LAL) Deficiency Treatment
    2.4 Market Channel Analysis of Lysosomal Acid Lipase (LAL) Deficiency Treatment
    2.5 Major Down Stream Customers by Application
    3 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Market, by Type
    3.1 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Revenue and Market Share by Type (2016-2021)
    3.2 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Production and Market Share by Type (2016-2021)
    3.3 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Revenue and Growth Rate by Type (2016-2021)
    3.3.1 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Revenue and Growth Rate of Wolman Disease (WD)
    3.3.2 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Revenue and Growth Rate of Cholesteryl Ester Storage Disease (CESD)
    3.4 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Price Analysis by Type (2016-2021)
    3.4.1 Explanation of Different Type Product Price Trends
    4 Lysosomal Acid Lipase (LAL) Deficiency Treatment Market, by Application
    4.1 Downstream Market Overview
    4.2 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Market Share by Application (2016-2021)
    4.3 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate by Application (2016-2021)
    4.3.1 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate of Enzyme Replacement Therapy (2016-2021)
    4.3.2 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate of Lipid-Modifying Agents (Statins) (2016-2021)
    4.3.3 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate of Surgery (Liver Transplant) (2016-2021)
    4.3.4 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate of Stem Cell Transplantation (2016-2021)
    4.3.5 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate of Supportive Care (2016-2021)
    5 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue ($) by Region (2016-2021)
    5.1 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Revenue and Market Share by Region (2016-2021)
    5.2 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Market Share by Region (2016-2021)
    5.3 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.4 North America Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.4.1 North America Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.4.2 North America Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    5.5 Europe Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.5.1 Europe Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.5.2 Europe Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    5.6 China Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.6.1 China Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.6.2 China Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    5.7 Japan Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.7.1 Japan Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.7.2 Japan Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    5.8 Middle East and Africa Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.8.1 Middle East and Africa Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.8.2 Middle East and Africa Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    5.9 India Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.9.1 India Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.9.2 India Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    5.10 South America Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.10.1 South America Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.10.2 South America Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    5.11 South Korea Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.11.1 South Korea Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.11.2 South Korea Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    5.12 Southeast Asia Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption, Revenue, Price and Gross Margin (2016-2021)
    5.12.1 Southeast Asia Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Under COVID-19
    5.12.2 Southeast Asia Lysosomal Acid Lipase (LAL) Deficiency Treatment SWOT Analysis
    6 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Production by Top Regions (2016-2021)
    6.1 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Production by Top Regions (2016-2021)
    6.2 North America Lysosomal Acid Lipase (LAL) Deficiency Treatment Production and Growth Rate
    6.3 Europe Lysosomal Acid Lipase (LAL) Deficiency Treatment Production and Growth Rate
    6.4 China Lysosomal Acid Lipase (LAL) Deficiency Treatment Production and Growth Rate
    6.5 Japan Lysosomal Acid Lipase (LAL) Deficiency Treatment Production and Growth Rate
    6.6 India Lysosomal Acid Lipase (LAL) Deficiency Treatment Production and Growth Rate
    7 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption by Regions (2016-2021)
    7.1 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption by Regions (2016-2021)
    7.2 North America Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    7.3 Europe Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    7.4 China Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    7.5 Japan Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    7.6 Middle East and Africa Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    7.7 India Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    7.8 South America Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    7.9 South Korea Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    7.10 Southeast Asia Lysosomal Acid Lipase (LAL) Deficiency Treatment Consumption and Growth Rate
    8 Competitive Landscape
    8.1 Competitive Profile
    8.2 Pfizer, Inc Market Performance Analysis
    8.2.1 Company Profiles
    8.2.2 Lysosomal Acid Lipase (LAL) Deficiency Treatment Product Profiles, Application and Specification
    8.2.3 Pfizer, Inc Sales, Revenue, Price, Gross Margin 2016-2021
    8.2.4 Company Recent Development
    8.2.5 Strategies for Company to Deal with the Impact of COVID-19
    8.3 Merck and Co., Inc Market Performance Analysis
    8.3.1 Company Profiles
    8.3.2 Lysosomal Acid Lipase (LAL) Deficiency Treatment Product Profiles, Application and Specification
    8.3.3 Merck and Co., Inc Sales, Revenue, Price, Gross Margin 2016-2021
    8.3.4 Company Recent Development
    8.3.5 Strategies for Company to Deal with the Impact of COVID-19
    8.4 AstraZeneca plc Market Performance Analysis
    8.4.1 Company Profiles
    8.4.2 Lysosomal Acid Lipase (LAL) Deficiency Treatment Product Profiles, Application and Specification
    8.4.3 AstraZeneca plc Sales, Revenue, Price, Gross Margin 2016-2021
    8.4.4 Company Recent Development
    8.4.5 Strategies for Company to Deal with the Impact of COVID-19
    8.5 Alexion Pharmaceutical Inc Market Performance Analysis
    8.5.1 Company Profiles
    8.5.2 Lysosomal Acid Lipase (LAL) Deficiency Treatment Product Profiles, Application and Specification
    8.5.3 Alexion Pharmaceutical Inc Sales, Revenue, Price, Gross Margin 2016-2021
    8.5.4 Company Recent Development
    8.5.5 Strategies for Company to Deal with the Impact of COVID-19
    8.6 Teva Pharmaceutical Industries Ltd. Market Performance Analysis
    8.6.1 Company Profiles
    8.6.2 Lysosomal Acid Lipase (LAL) Deficiency Treatment Product Profiles, Application and Specification
    8.6.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue, Price, Gross Margin 2016-2021
    8.6.4 Company Recent Development
    8.6.5 Strategies for Company to Deal with the Impact of COVID-19
    9 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Analysis and Forecast by Type and Application
    9.1 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Revenue and Volume Forecast, by Type (2021-2026)
    9.1.1 Wolman Disease (WD) Market Revenue and Volume Forecast (2021-2026)
    9.1.2 Cholesteryl Ester Storage Disease (CESD) Market Revenue and Volume Forecast (2021-2026)
    9.2 Global Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Revenue and Volume Forecast, by Application (2021-2026)
    9.2.1 Enzyme Replacement Therapy Market Revenue and Volume Forecast (2021-2026)
    9.2.2 Lipid-Modifying Agents (Statins) Market Revenue and Volume Forecast (2021-2026)
    9.2.3 Surgery (Liver Transplant) Market Revenue and Volume Forecast (2021-2026)
    9.2.4 Stem Cell Transplantation Market Revenue and Volume Forecast (2021-2026)
    9.2.5 Supportive Care Market Revenue and Volume Forecast (2021-2026)
    10 Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Supply and Demand Forecast by Region
    10.1 North America Market Supply and Demand Forecast (2021-2026)
    10.2 Europe Market Supply and Demand Forecast (2021-2026)
    10.3 China Market Supply and Demand Forecast (2021-2026)
    10.4 Japan Market Supply and Demand Forecast (2021-2026)
    10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
    10.6 India Market Supply and Demand Forecast (2021-2026)
    10.7 South America Market Supply and Demand Forecast (2021-2026)
    10.8 South Korea Market Supply and Demand Forecast (2021-2026)
    10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
    10.10 Explanation of Market Size Trends by Region
    10.11 Lysosomal Acid Lipase (LAL) Deficiency Treatment Market Trends Analysis
    11 New Project Feasibility Analysis
    11.1 Industry Barriers and New Entrants SWOT Analysis
    11.2 Analysis and Suggestions on New Project Investment
    12 Expert Interview Record
    13 Research Finding and Conclusion
    14 Appendix
    14.1 Methodology
    14.2 Research Data Source
     

    Continued

    Browse the complete table of contents at -

    About Us:

    Market Reports World is the Credible Source for Gaining the Market Reports that will Provide you with the Lead Your Business Needs. Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today's businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors.

    Contact Us:

    Market Reports World

    Phone: US : +(1) 424 253 0946
    UK : +(44) 203 239 8187
    Email:
    Web: Release Distributed by the express wire

    To view the original version on The Express Wire visit lysosomal acid lipase (lal) deficiency treatment market size and share report 2023-2030

  • MENAFN28032023004576010663ID1105888853


    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.